Loading
No insider purchase over the last 90 days. The latest, by Kotaieva Anastasiia, was filed 10 Oct 2025.
Nukkleus Inc.: what insiders have been doing
Every trade that managers of Nukkleus Inc. disclose to SEC (Form 4) is tracked on this page. The company sits in the Banks sector. 6 insiders have disclosed 16 filings since 22 October 2025.
All open-market trades in the period are sales: 8 sales worth €1.7M, by 1 insider, with no purchase on record. Kotaieva Anastasiia filed the largest sale, €272k, on 29 December 2025.
The median gap between a trade and its publication by SEC (Form 4) is 5 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
With 16 filings in twelve months, the company is quieter than the median of 24 filings across the 3,171 companies we follow on the same exchange. Our records for Nukkleus Inc. go back to 2021, with 8 purchases and 9 sales on the open market in total.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
36
Thresholds
n/a
Buy Volume
€950,738
8 ops. · all time
Sell Volume
€2M
9 ops. · all time
Who traded when
BuySaleAnastasiia Kotaieva4 buys8 sales
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
Income statement
Gross profitUS$859.7k
Net incomeUS$67.6M
Last declaration on 29 January 2026
Declarations36 total
200,000 shares@ US$1.5027.5% of flowCommon Stock $0.0001 par value per shareSEC:0001213900-26-009491:0
1,992,010 shares0Common Stock$0.0001 par value per shareSEC:0001213900-26-005839:0
75,000 shares@ US$4.037.7% of flowCommon Stock, $0.0001 par value per shareSEC:0001213900-25-127149:1
75,000 shares@ US$4.090218.8% of flowCommon Stock, $0.0001 par value per shareSEC:0001213900-25-127149:0
70,000 shares@ US$4.578.2% of flowCommon Stock, $0.0001 par value per shareSEC:0001213900-25-126147:1
55,604 shares@ US$4.496.4% of flowCommon Stock, $0.0001 par value per shareSEC:0001213900-25-126147:2
55,604 shares@ US$4.266.1% of flowCommon Stock, $0.0001 par value per shareSEC:0001213900-25-126147:3
30,000 shares@ US$4.41468.1% of flowCommon Stock, $0.0001 par value per shareSEC:0001213900-25-126147:0
70,000 shares@ US$4.538.2% of flowCommon Stock, $0.0001 par value per shareSEC:0001213900-25-124543:1
38,744 shares@ US$4.722211.2% of flowCommon Stock, $0.0001 par value per shareSEC:0001213900-25-124543:0
5,000 shares0Common Stock, $0.0001 par value per shareSEC:0001213900-25-113015:0
10,000 shares0Common Stock, $0.0001 par value per shareSEC:0001213900-25-113013:0
5,000 shares0Common Stock, $0.0001 par value per shareSEC:0001213900-25-113009:0
5,000 shares0Common Stock, $0.0001 par value per shareSEC:0001213900-25-113008:0
750,000 shares0Common Stock, $0.0001 par value per shareSEC:0001213900-25-111632:0
377,432 shares0Common Stock, $0.0001 par value per shareSEC:0001213900-25-102188:0
259,864 sharesCommon Stock, $0.0001 par value per shareSEC:0001213900-25-098218:1
Canonical exit: 7 Jan 2026 (T+90)
999,989 sharesCommon Stock, $0.0001 par value per shareSEC:0001213900-25-098218:2
Canonical exit: 7 Jan 2026 (T+90)
117,568 sharesCommon Stock, $0.0001 par value per shareSEC:0001213900-25-098218:0
Canonical exit: 6 Jan 2026 (T+90)
150,000 shares@ US$1.3914.3% of flowCommon Stock, $0.0001 par value per shareSEC:0001213900-24-111518:0
319,952 shares@ US$2.4121.5% of flowCommon Stock, $0.0001 par value per shareSEC:0001213900-24-111167:1
Canonical exit: 6 Feb 2025 (T+90)
10,000 shares@ US$1.39100.0% of flowCommon Stock, $0.0001 par value per shareSEC:0001213900-24-111166:0
500,000 shares@ US$1.3947.6% of flowCommon Stock, $0.0001 par value per shareSEC:0001213900-24-111167:0
10,000 shares@ US$1.39100.0% of flowCommon Stock, $0.0001 par value per shareSEC:0001213900-24-111168:0
10,000 shares@ US$1.39100.0% of flowCommon Stock, $0.0001 par value per shareSEC:0001213900-24-111170:0
25 of 36 declarations
About Nukkleus Inc.
Nukkleus Inc. is a US-listed company traded on NASDAQ in the United States, and it has undergone a notable strategic transformation over the past several quarters. Historically, the company was associated with fintech, digital asset execution, multi-asset trading technology, and fiat-to-crypto payment rails. More recently, management has repositioned the business toward aerospace and defense, using an acquisition-led model to build a portfolio of specialized industrial assets. For investors, that shift is important: the equity story is no longer primarily about legacy fintech exposure, but about whether the company can execute a defense-focused roll-up strategy. ([nukk.com](https://www.nukk.com/news/nukkleus-inc-acquires-london-based-match-financial-limited/?utm_source=openai))
The company’s earlier business model was centered on financial technology services, including institutional trading infrastructure, liquidity access, crypto-related execution, and global payments. That heritage still matters because it explains Nukkleus’s core operating style: identify niche capabilities, acquire them, and try to scale them through technology, distribution, and capital markets access. Over time, however, the company broadened its ambitions and began to present itself as a strategic acquirer and developer of high-growth aerospace and defense businesses. ([nukk.com](https://www.nukk.com/news/nukkleus-inc-acquires-london-based-match-financial-limited/?utm_source=openai))
Read moreShow less
Its current core initiatives are concentrated in defense-related verticals. Nukkleus announced the creation of Nukkleus Defense Technologies and later highlighted an exclusive U.S. distribution agreement with BladeRanger for drone payload solutions. The company also disclosed the acquisition of Tiltan Software Engineering, described as an Israeli developer of synthetic defense data generation, GPS-denied navigation solutions, and hardware-in-the-loop / software-in-the-loop simulator systems. Taken together, these announcements indicate a focus on niche mission-critical technologies rather than broad-based manufacturing. ([globenewswire.com](https://www.globenewswire.com/news-release/2025/08/26/3139444/0/en/nukkleus-launches-defense-subsidiary-and-secures-exclusive-u-s-distribution-agreement-with-bladeranger-to-capitalize-on-booming-drone-payload-market.html?utm_source=openai))
From a competitive standpoint, Nukkleus remains a small-cap, transformation-stage company competing in a fragmented market of defense suppliers, technology integrators, and acquisition platforms. Its potential advantage lies in capital allocation discipline, deal sourcing, and the ability to combine software, simulation, drone-related payloads, and distribution into a coherent defense platform. Its disadvantages are equally clear: integration risk, financing dependence, and a relatively short operating track record in the defense segment. The company itself has flagged execution, capital, and market-adoption risks in recent communications. ([globenewswire.com](https://www.globenewswire.com/news-release/2026/01/22/3224263/0/en/nukkleus-inc-provides-updates-on-acquisitions-and-outlines-its-2026-growth-strategy.html?utm_source=openai))
Geographically, Nukkleus is a United States company, with SEC filings indicating its principal executive offices in Jersey City, New Jersey. The group’s recent deal activity also points to an international footprint, including Israeli defense-related assets and prior UK-linked financial technology operations. That global mix gives the company optionality, but it also increases complexity for investors assessing governance, execution, and strategic coherence. For French, Belgian, and Swiss investors, the key takeaway is that Nukkleus is a NASDAQ-listed US company in transition, with recent news dominated by acquisitions, restructuring, and a formal rebrand toward defense. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1787518/000121390025011694/0001213900-25-011694-index.htm?utm_source=openai))
